Literature DB >> 20388630

Strict glycaemic control in diabetic patients with CKD or ESRD: beneficial or deadly?

Guntram Schernthaner1, Eberhard Ritz, Gerit-Holger Schernthaner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388630     DOI: 10.1093/ndt/gfq199

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  15 in total

Review 1.  Haemodialysis-induced hypoglycaemia and glycaemic disarrays.

Authors:  Masanori Abe; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2015-04-07       Impact factor: 28.314

Review 2.  Update on glycemic control for the treatment of diabetic kidney disease.

Authors:  Girish N Nadkarni; Rabi Yacoub; Steven G Coca
Journal:  Curr Diab Rep       Date:  2015-07       Impact factor: 4.810

3.  [Current treatment of type 2 diabetes].

Authors:  G Schernthaner; G-H Schernthaner
Journal:  Internist (Berl)       Date:  2012-12       Impact factor: 0.743

Review 4.  Diabetes treatment in patients with renal disease: Is the landscape clear enough?

Authors:  Ioannis Ioannidis
Journal:  World J Diabetes       Date:  2014-10-15

Review 5.  Limitations and future treatment options in type 2 diabetes with renal impairment.

Authors:  Eberhard Ritz
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

6.  Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management.

Authors:  Panagiotis Pateinakis; Aikaterini Papagianni
Journal:  Int J Nephrol       Date:  2011-02-06

Review 7.  The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Authors:  Guntram Schernthaner; Carl Erik Mogensen; Gerit-Holger Schernthaner
Journal:  Diab Vasc Dis Res       Date:  2014-09       Impact factor: 3.291

8.  Dysglycemia but not lipids is associated with abnormal urinary albumin excretion in diabetic kidney disease: a report from the Kidney Early Evaluation Program (KEEP).

Authors:  Subhasish Bose; Andrew S Bomback; Nehal N Mehta; Shu-Cheng Chen; Suying Li; Adam Whaley-Connell; Joseph Benjamin; Peter A McCullough
Journal:  BMC Nephrol       Date:  2012-09-07       Impact factor: 2.388

9.  Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.

Authors:  Hasniza Zaman Huri; Lay Peng Lim; Soo Kun Lim
Journal:  Drug Des Devel Ther       Date:  2015-08-07       Impact factor: 4.162

10.  Long-term efficacy of vildagliptin in patients with type 2 diabetes undergoing hemodialysis.

Authors:  Jun-Ichiro Mera; Eiko Okada; Masumi Okuda; Tatsuru Ota; Shigeru Sibata; Shunya Uchida
Journal:  J Diabetes Metab Disord       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.